Elevated serum galectin-1 concentrations are associated with increased risks of mortality and acute kidney injury in critically ill patients.

<h4>Background</h4>Galectin-1 (Gal-1), a member of the β-galactoside binding protein family, is associated with inflammation and chronic kidney disease. However, the effect of Gal-1 on mortality and acute kidney injury (AKI) in critically-ill patients remain unclear.<h4>Methods<...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Ruey-Hsing Chou, Chuan-Tsai Tsai, Ya-Wen Lu, Jiun-Yu Guo, Chi-Ting Lu, Yi-Lin Tsai, Cheng-Hsueh Wu, Shing-Jong Lin, Ru-Yu Lien, Shu-Fen Lu, Shang-Feng Yang, Po-Hsun Huang
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/bf158a500f5e4e2dbf98332fc767efdf
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:bf158a500f5e4e2dbf98332fc767efdf
record_format dspace
spelling oai:doaj.org-article:bf158a500f5e4e2dbf98332fc767efdf2021-12-02T20:08:00ZElevated serum galectin-1 concentrations are associated with increased risks of mortality and acute kidney injury in critically ill patients.1932-620310.1371/journal.pone.0257558https://doaj.org/article/bf158a500f5e4e2dbf98332fc767efdf2021-01-01T00:00:00Zhttps://doi.org/10.1371/journal.pone.0257558https://doaj.org/toc/1932-6203<h4>Background</h4>Galectin-1 (Gal-1), a member of the β-galactoside binding protein family, is associated with inflammation and chronic kidney disease. However, the effect of Gal-1 on mortality and acute kidney injury (AKI) in critically-ill patients remain unclear.<h4>Methods</h4>From May 2018 to March 2020, 350 patients admitted to the medical intensive care unit (ICU) of Taipei Veterans General Hospital, a tertiary medical center, were enrolled in this study. Forty-one patients receiving long-term renal replacement therapy were excluded. Serum Gal-1 levels were determined within 24 h of ICU admission. The patients were divided into tertiles according to their serum Gal-1 levels (low, serum Gal-1 < 39 ng/ml; median, 39-70 ng/ml; high, ≥71 ng/ml). All patients were followed for 90 days or until death.<h4>Results</h4>Mortality in the ICU and at 90 days was greater among patients with elevated serum Gal-1 levels. In analyses adjusted for the body mass index, malignancy, sepsis, Sequential Organ Failure Assessment (SOFA) score, and serum lactate level, the serum Gal-1 level remained an independent predictor of 90-day mortality [median vs. low: adjusted hazard ratio (aHR) 2.11, 95% confidence interval (CI) 1.24-3.60, p = 0.006; high vs. low: aHR 3.21, 95% CI 1.90-5.42, p < 0.001]. Higher serum Gal-1 levels were also associated with a higher incidence of AKI within 48 h after ICU admission, independent of the SOFA score and renal function (median vs. low: aHR 2.77, 95% CI 1.21-6.34, p = 0.016; high vs. low: aHR 2.88, 95% CI 1.20-6.88, p = 0.017). The results were consistent among different subgroups with high and low Gal-1 levels.<h4>Conclusion</h4>Serum Gal-1 elevation at the time of ICU admission were associated with an increased risk of mortality at 90 days, and an increased incidence of AKI within 48 h after ICU admission.Ruey-Hsing ChouChuan-Tsai TsaiYa-Wen LuJiun-Yu GuoChi-Ting LuYi-Lin TsaiCheng-Hsueh WuShing-Jong LinRu-Yu LienShu-Fen LuShang-Feng YangPo-Hsun HuangPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 16, Iss 9, p e0257558 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Ruey-Hsing Chou
Chuan-Tsai Tsai
Ya-Wen Lu
Jiun-Yu Guo
Chi-Ting Lu
Yi-Lin Tsai
Cheng-Hsueh Wu
Shing-Jong Lin
Ru-Yu Lien
Shu-Fen Lu
Shang-Feng Yang
Po-Hsun Huang
Elevated serum galectin-1 concentrations are associated with increased risks of mortality and acute kidney injury in critically ill patients.
description <h4>Background</h4>Galectin-1 (Gal-1), a member of the β-galactoside binding protein family, is associated with inflammation and chronic kidney disease. However, the effect of Gal-1 on mortality and acute kidney injury (AKI) in critically-ill patients remain unclear.<h4>Methods</h4>From May 2018 to March 2020, 350 patients admitted to the medical intensive care unit (ICU) of Taipei Veterans General Hospital, a tertiary medical center, were enrolled in this study. Forty-one patients receiving long-term renal replacement therapy were excluded. Serum Gal-1 levels were determined within 24 h of ICU admission. The patients were divided into tertiles according to their serum Gal-1 levels (low, serum Gal-1 < 39 ng/ml; median, 39-70 ng/ml; high, ≥71 ng/ml). All patients were followed for 90 days or until death.<h4>Results</h4>Mortality in the ICU and at 90 days was greater among patients with elevated serum Gal-1 levels. In analyses adjusted for the body mass index, malignancy, sepsis, Sequential Organ Failure Assessment (SOFA) score, and serum lactate level, the serum Gal-1 level remained an independent predictor of 90-day mortality [median vs. low: adjusted hazard ratio (aHR) 2.11, 95% confidence interval (CI) 1.24-3.60, p = 0.006; high vs. low: aHR 3.21, 95% CI 1.90-5.42, p < 0.001]. Higher serum Gal-1 levels were also associated with a higher incidence of AKI within 48 h after ICU admission, independent of the SOFA score and renal function (median vs. low: aHR 2.77, 95% CI 1.21-6.34, p = 0.016; high vs. low: aHR 2.88, 95% CI 1.20-6.88, p = 0.017). The results were consistent among different subgroups with high and low Gal-1 levels.<h4>Conclusion</h4>Serum Gal-1 elevation at the time of ICU admission were associated with an increased risk of mortality at 90 days, and an increased incidence of AKI within 48 h after ICU admission.
format article
author Ruey-Hsing Chou
Chuan-Tsai Tsai
Ya-Wen Lu
Jiun-Yu Guo
Chi-Ting Lu
Yi-Lin Tsai
Cheng-Hsueh Wu
Shing-Jong Lin
Ru-Yu Lien
Shu-Fen Lu
Shang-Feng Yang
Po-Hsun Huang
author_facet Ruey-Hsing Chou
Chuan-Tsai Tsai
Ya-Wen Lu
Jiun-Yu Guo
Chi-Ting Lu
Yi-Lin Tsai
Cheng-Hsueh Wu
Shing-Jong Lin
Ru-Yu Lien
Shu-Fen Lu
Shang-Feng Yang
Po-Hsun Huang
author_sort Ruey-Hsing Chou
title Elevated serum galectin-1 concentrations are associated with increased risks of mortality and acute kidney injury in critically ill patients.
title_short Elevated serum galectin-1 concentrations are associated with increased risks of mortality and acute kidney injury in critically ill patients.
title_full Elevated serum galectin-1 concentrations are associated with increased risks of mortality and acute kidney injury in critically ill patients.
title_fullStr Elevated serum galectin-1 concentrations are associated with increased risks of mortality and acute kidney injury in critically ill patients.
title_full_unstemmed Elevated serum galectin-1 concentrations are associated with increased risks of mortality and acute kidney injury in critically ill patients.
title_sort elevated serum galectin-1 concentrations are associated with increased risks of mortality and acute kidney injury in critically ill patients.
publisher Public Library of Science (PLoS)
publishDate 2021
url https://doaj.org/article/bf158a500f5e4e2dbf98332fc767efdf
work_keys_str_mv AT rueyhsingchou elevatedserumgalectin1concentrationsareassociatedwithincreasedrisksofmortalityandacutekidneyinjuryincriticallyillpatients
AT chuantsaitsai elevatedserumgalectin1concentrationsareassociatedwithincreasedrisksofmortalityandacutekidneyinjuryincriticallyillpatients
AT yawenlu elevatedserumgalectin1concentrationsareassociatedwithincreasedrisksofmortalityandacutekidneyinjuryincriticallyillpatients
AT jiunyuguo elevatedserumgalectin1concentrationsareassociatedwithincreasedrisksofmortalityandacutekidneyinjuryincriticallyillpatients
AT chitinglu elevatedserumgalectin1concentrationsareassociatedwithincreasedrisksofmortalityandacutekidneyinjuryincriticallyillpatients
AT yilintsai elevatedserumgalectin1concentrationsareassociatedwithincreasedrisksofmortalityandacutekidneyinjuryincriticallyillpatients
AT chenghsuehwu elevatedserumgalectin1concentrationsareassociatedwithincreasedrisksofmortalityandacutekidneyinjuryincriticallyillpatients
AT shingjonglin elevatedserumgalectin1concentrationsareassociatedwithincreasedrisksofmortalityandacutekidneyinjuryincriticallyillpatients
AT ruyulien elevatedserumgalectin1concentrationsareassociatedwithincreasedrisksofmortalityandacutekidneyinjuryincriticallyillpatients
AT shufenlu elevatedserumgalectin1concentrationsareassociatedwithincreasedrisksofmortalityandacutekidneyinjuryincriticallyillpatients
AT shangfengyang elevatedserumgalectin1concentrationsareassociatedwithincreasedrisksofmortalityandacutekidneyinjuryincriticallyillpatients
AT pohsunhuang elevatedserumgalectin1concentrationsareassociatedwithincreasedrisksofmortalityandacutekidneyinjuryincriticallyillpatients
_version_ 1718375265511407616